MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 24.02.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
1995 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
92.6 M |
Marktkapitalisierung |
$ 457 M |
EBITDA (LTM) |
$ -390 M |
P/E (LTM) |
-1.11 |
P/S (LTM) |
0.55 |
EPS (LTM) |
-4.51 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
$ 2.83 | -4.39 % | $ 91.8 K | Nasdaq Capital Market | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 116.37 | -1.49 % | $ 35.4 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 105.97 | -2.15 % | $ 4.18 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Charles River Laboratories International
CRL
|
$ 173.71 | -2.76 % | $ 8.61 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 27.4 | -2.11 % | $ 761 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 15.93 | 1.14 % | $ 2.07 B | Nasdaq Global Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 13.83 | -2.61 % | $ 418 M | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.11 | -3.07 % | $ 1.41 M | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 205.94 | -2.06 % | $ 22.9 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 202.02 | -1.88 % | $ 144 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.3 | -0.05 % | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.64 | -1.48 % | $ 541 M | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.5 | -2.33 % | $ 298 M | Nasdaq Capital Market |  Israel |
 |
DexCom
DXCM
|
$ 73.05 | -1.0 % | $ 28.5 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
$ 24.2 | -3.82 % | $ 258 M | Nasdaq Global Market | China |
 |
CareDx, Inc
CDNA
|
$ 18.27 | -2.53 % | $ 974 M | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 105.46 | -2.6 % | $ 8.7 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 642.76 | 0.95 % | $ 51.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Illumina
ILMN
|
$ 128.99 | -2.93 % | $ 20.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 90.81 | -1.54 % | $ 11.4 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 171.78 | -1.43 % | $ 29.5 B | NYSE,SPB | USA |
 |
Brainsway Ltd.
BWAY
|
$ 22.69 | -4.22 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
$ 280.06 | -2.17 % | $ 23.3 B | NYSE,SPB | USA |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 77.65 | 1.77 % | $ 5.24 B | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 309.79 | -1.0 % | $ 27 B | NYSE,SPB |  Schweiz |
 |
NeoGenomics
NEO
|
$ 9.13 | -3.89 % | $ 1.17 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 200.13 | 0.2 % | $ 19.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.51 | -7.1 % | $ 453 M | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 10.97 | -1.61 % | $ 2.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Precipio
PRPO
|
$ 24.5 | -0.73 % | $ 31.8 M | Nasdaq Global Select Market | USA |